DOUGLAS B. GIVEN - 28 Dec 2021 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/ Douglass Given
Issuer symbol
ARWR
Transactions as of
28 Dec 2021
Net transactions value
+$43,472
Form type
4
Filing time
29 Dec 2021, 19:44:11 UTC
Previous filing
10 Sep 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Gift $0 -655 -0.6% $0.000000 109,213 28 Dec 2021 Direct
transaction ARWR Common Stock Purchase $43,472 +655 +0.6% $66.37 109,868 28 Dec 2021 Direct F1
holding ARWR Common Stock 13,875 28 Dec 2021 By Trust F2
holding ARWR Common Stock 12,500 28 Dec 2021 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
F2 Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
F3 Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.